CA2394891A1 - Substituted phthalocyanines and their precursors - Google Patents
Substituted phthalocyanines and their precursors Download PDFInfo
- Publication number
- CA2394891A1 CA2394891A1 CA002394891A CA2394891A CA2394891A1 CA 2394891 A1 CA2394891 A1 CA 2394891A1 CA 002394891 A CA002394891 A CA 002394891A CA 2394891 A CA2394891 A CA 2394891A CA 2394891 A1 CA2394891 A1 CA 2394891A1
- Authority
- CA
- Canada
- Prior art keywords
- substituted
- optionally substituted
- formula
- alkyl
- different
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002243 precursor Substances 0.000 title description 7
- 229920006391 phthalonitrile polymer Polymers 0.000 claims abstract description 176
- 238000000034 method Methods 0.000 claims abstract description 157
- -1 phthalonitrile sulfonate esters Chemical class 0.000 claims abstract description 123
- 238000002360 preparation method Methods 0.000 claims abstract description 119
- 230000008569 process Effects 0.000 claims abstract description 81
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical class N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 claims description 186
- 125000001246 bromo group Chemical group Br* 0.000 claims description 156
- XQZYPMVTSDWCCE-UHFFFAOYSA-N phthalonitrile Chemical compound N#CC1=CC=CC=C1C#N XQZYPMVTSDWCCE-UHFFFAOYSA-N 0.000 claims description 155
- 238000006243 chemical reaction Methods 0.000 claims description 149
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 136
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 92
- 125000000217 alkyl group Chemical group 0.000 claims description 78
- 125000001424 substituent group Chemical group 0.000 claims description 70
- 239000000203 mixture Substances 0.000 claims description 68
- 125000003342 alkenyl group Chemical group 0.000 claims description 61
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 51
- 229910052763 palladium Inorganic materials 0.000 claims description 51
- 125000003118 aryl group Chemical group 0.000 claims description 50
- 239000007787 solid Substances 0.000 claims description 48
- 150000001875 compounds Chemical class 0.000 claims description 47
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 47
- 229910052725 zinc Inorganic materials 0.000 claims description 43
- 125000003358 C2-C20 alkenyl group Chemical group 0.000 claims description 40
- 238000006880 cross-coupling reaction Methods 0.000 claims description 37
- 239000003153 chemical reaction reagent Substances 0.000 claims description 35
- 229920000642 polymer Polymers 0.000 claims description 35
- 229920006395 saturated elastomer Polymers 0.000 claims description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 29
- 125000001072 heteroaryl group Chemical group 0.000 claims description 29
- 150000004820 halides Chemical class 0.000 claims description 24
- 230000002093 peripheral effect Effects 0.000 claims description 24
- 125000000304 alkynyl group Chemical group 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 23
- 229920001184 polypeptide Polymers 0.000 claims description 22
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 22
- 150000001413 amino acids Chemical class 0.000 claims description 21
- 229910052759 nickel Inorganic materials 0.000 claims description 21
- 206010028980 Neoplasm Diseases 0.000 claims description 20
- 229910052751 metal Inorganic materials 0.000 claims description 20
- 239000002184 metal Substances 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 20
- 108090000623 proteins and genes Proteins 0.000 claims description 20
- 150000001720 carbohydrates Chemical class 0.000 claims description 19
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 19
- 239000000194 fatty acid Substances 0.000 claims description 19
- 229930195729 fatty acid Natural products 0.000 claims description 19
- 150000004665 fatty acids Chemical class 0.000 claims description 19
- 150000004676 glycans Chemical class 0.000 claims description 19
- 150000007523 nucleic acids Chemical class 0.000 claims description 19
- 102000039446 nucleic acids Human genes 0.000 claims description 19
- 108020004707 nucleic acids Proteins 0.000 claims description 19
- 229920001282 polysaccharide Polymers 0.000 claims description 19
- 239000005017 polysaccharide Substances 0.000 claims description 19
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 18
- 229910052749 magnesium Inorganic materials 0.000 claims description 16
- 238000002428 photodynamic therapy Methods 0.000 claims description 16
- MPAIWVOBMLSHQA-UHFFFAOYSA-N 3,6-dihydroxybenzene-1,2-dicarbonitrile Chemical class OC1=CC=C(O)C(C#N)=C1C#N MPAIWVOBMLSHQA-UHFFFAOYSA-N 0.000 claims description 15
- 229910052697 platinum Inorganic materials 0.000 claims description 15
- 229910052710 silicon Inorganic materials 0.000 claims description 15
- 229910052782 aluminium Inorganic materials 0.000 claims description 14
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 14
- 239000008194 pharmaceutical composition Substances 0.000 claims description 14
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims description 13
- 238000005859 coupling reaction Methods 0.000 claims description 13
- 150000002148 esters Chemical class 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 230000005855 radiation Effects 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 11
- 230000008878 coupling Effects 0.000 claims description 11
- 238000010168 coupling process Methods 0.000 claims description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
- 208000031295 Animal disease Diseases 0.000 claims description 10
- 229910052794 bromium Inorganic materials 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 206010020718 hyperplasia Diseases 0.000 claims description 10
- 229910052740 iodine Inorganic materials 0.000 claims description 10
- 239000007819 coupling partner Substances 0.000 claims description 9
- 230000005670 electromagnetic radiation Effects 0.000 claims description 9
- 125000004429 atom Chemical group 0.000 claims description 8
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims description 8
- 150000002367 halogens Chemical group 0.000 claims description 8
- 230000003647 oxidation Effects 0.000 claims description 8
- 238000007254 oxidation reaction Methods 0.000 claims description 8
- 230000001413 cellular effect Effects 0.000 claims description 7
- 230000005292 diamagnetic effect Effects 0.000 claims description 7
- 229910052732 germanium Inorganic materials 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 229910052738 indium Inorganic materials 0.000 claims description 7
- 229910001509 metal bromide Inorganic materials 0.000 claims description 7
- 229910001510 metal chloride Inorganic materials 0.000 claims description 7
- 229910044991 metal oxide Inorganic materials 0.000 claims description 7
- 150000004706 metal oxides Chemical class 0.000 claims description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 7
- 239000010703 silicon Substances 0.000 claims description 7
- 201000004681 Psoriasis Diseases 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 229910052733 gallium Inorganic materials 0.000 claims description 6
- 229910052742 iron Inorganic materials 0.000 claims description 6
- 229910052747 lanthanoid Inorganic materials 0.000 claims description 6
- 150000002602 lanthanoids Chemical class 0.000 claims description 6
- 229910052745 lead Inorganic materials 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 229910052758 niobium Inorganic materials 0.000 claims description 6
- 229910052718 tin Inorganic materials 0.000 claims description 6
- 229910052720 vanadium Inorganic materials 0.000 claims description 6
- 208000015602 Actinic lichen planus Diseases 0.000 claims description 5
- 208000037260 Atherosclerotic Plaque Diseases 0.000 claims description 5
- 208000035143 Bacterial infection Diseases 0.000 claims description 5
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims description 5
- 201000004624 Dermatitis Diseases 0.000 claims description 5
- 208000031220 Hemophilia Diseases 0.000 claims description 5
- 208000009292 Hemophilia A Diseases 0.000 claims description 5
- 208000031888 Mycoses Diseases 0.000 claims description 5
- 206010057469 Vascular stenosis Diseases 0.000 claims description 5
- 208000009621 actinic keratosis Diseases 0.000 claims description 5
- 230000002152 alkylating effect Effects 0.000 claims description 5
- 206010003246 arthritis Diseases 0.000 claims description 5
- 208000010668 atopic eczema Diseases 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 230000002538 fungal effect Effects 0.000 claims description 5
- 230000002757 inflammatory effect Effects 0.000 claims description 5
- 230000003211 malignant effect Effects 0.000 claims description 5
- 201000005962 mycosis fungoides Diseases 0.000 claims description 5
- 239000012038 nucleophile Substances 0.000 claims description 5
- 201000008482 osteoarthritis Diseases 0.000 claims description 5
- 208000037803 restenosis Diseases 0.000 claims description 5
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 230000002792 vascular Effects 0.000 claims description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 5
- 230000003612 virological effect Effects 0.000 claims description 5
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 229920000728 polyester Polymers 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 4
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims description 3
- 206010029113 Neovascularisation Diseases 0.000 claims description 3
- 230000001427 coherent effect Effects 0.000 claims description 3
- 229910021419 crystalline silicon Inorganic materials 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 230000000704 physical effect Effects 0.000 claims description 3
- 238000007920 subcutaneous administration Methods 0.000 claims description 3
- 230000009885 systemic effect Effects 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- 229920002732 Polyanhydride Polymers 0.000 claims description 2
- 229920001710 Polyorthoester Polymers 0.000 claims description 2
- 229920002988 biodegradable polymer Polymers 0.000 claims description 2
- 239000004621 biodegradable polymer Substances 0.000 claims description 2
- 229920001400 block copolymer Polymers 0.000 claims description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- 238000005286 illumination Methods 0.000 claims description 2
- OKPYIWASQZGASP-UHFFFAOYSA-N n-(2-hydroxypropyl)-2-methylprop-2-enamide Chemical group CC(O)CNC(=O)C(C)=C OKPYIWASQZGASP-UHFFFAOYSA-N 0.000 claims description 2
- 229920001308 poly(aminoacid) Polymers 0.000 claims description 2
- 229920002627 poly(phosphazenes) Polymers 0.000 claims description 2
- 125000003107 substituted aryl group Chemical group 0.000 claims description 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims 50
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 24
- 101100516554 Caenorhabditis elegans nhr-5 gene Proteins 0.000 claims 21
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 15
- 229910006069 SO3H Inorganic materials 0.000 claims 12
- 125000006755 (C2-C20) alkyl group Chemical group 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 102220009232 rs111430410 Human genes 0.000 claims 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 288
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 156
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 150
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 144
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 126
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 112
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 108
- 239000000243 solution Substances 0.000 description 102
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 90
- 239000003480 eluent Substances 0.000 description 78
- UHOVQNZJYSORNB-MZWXYZOWSA-N benzene-d6 Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 73
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 72
- 239000002904 solvent Substances 0.000 description 71
- 238000010992 reflux Methods 0.000 description 70
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 68
- 238000005481 NMR spectroscopy Methods 0.000 description 66
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 63
- 239000011701 zinc Substances 0.000 description 63
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 60
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 58
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 54
- 238000004440 column chromatography Methods 0.000 description 53
- 239000000047 product Substances 0.000 description 53
- 239000000377 silicon dioxide Substances 0.000 description 51
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 49
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 48
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 45
- 101150041968 CDC13 gene Proteins 0.000 description 42
- DSZGQEHPKNNPFU-UHFFFAOYSA-N 3,6-didecylbenzene-1,2-dicarbonitrile Chemical compound CCCCCCCCCCC1=CC=C(CCCCCCCCCC)C(C#N)=C1C#N DSZGQEHPKNNPFU-UHFFFAOYSA-N 0.000 description 41
- 238000005160 1H NMR spectroscopy Methods 0.000 description 37
- 239000002585 base Substances 0.000 description 35
- 210000004027 cell Anatomy 0.000 description 35
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 35
- 239000003208 petroleum Substances 0.000 description 35
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 33
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 32
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 31
- 235000019439 ethyl acetate Nutrition 0.000 description 31
- 239000012267 brine Substances 0.000 description 30
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 30
- 229910052757 nitrogen Inorganic materials 0.000 description 30
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 30
- 229910052786 argon Inorganic materials 0.000 description 29
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 28
- 229940093499 ethyl acetate Drugs 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 208000028257 Joubert syndrome with oculorenal defect Diseases 0.000 description 26
- 239000003054 catalyst Substances 0.000 description 26
- 238000001816 cooling Methods 0.000 description 26
- AYGKNJJGSMKDPA-UHFFFAOYSA-N 4-bromo-3,6-dibutoxybenzene-1,2-dicarbonitrile Chemical compound CCCCOC1=CC(Br)=C(OCCCC)C(C#N)=C1C#N AYGKNJJGSMKDPA-UHFFFAOYSA-N 0.000 description 25
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 25
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 22
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 21
- FCAPKPPCJBYHEC-UHFFFAOYSA-N [2,3-dicyano-4-(trifluoromethylsulfonyloxy)phenyl] trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC=C(OS(=O)(=O)C(F)(F)F)C(C#N)=C1C#N FCAPKPPCJBYHEC-UHFFFAOYSA-N 0.000 description 20
- 239000003921 oil Substances 0.000 description 20
- 239000000523 sample Substances 0.000 description 20
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 19
- 238000003756 stirring Methods 0.000 description 19
- 239000004246 zinc acetate Substances 0.000 description 19
- 239000012043 crude product Substances 0.000 description 18
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 17
- 239000013078 crystal Substances 0.000 description 17
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 16
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 15
- 230000000155 isotopic effect Effects 0.000 description 14
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 13
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 13
- LVIYYTJTOKJJOC-UHFFFAOYSA-N nickel phthalocyanine Chemical compound [Ni+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 LVIYYTJTOKJJOC-UHFFFAOYSA-N 0.000 description 13
- 238000003786 synthesis reaction Methods 0.000 description 13
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 12
- HAAHMAILBWIUSO-UHFFFAOYSA-N 4,5-dibromo-3,6-dibutoxybenzene-1,2-dicarbonitrile Chemical compound CCCCOC1=C(Br)C(Br)=C(OCCCC)C(C#N)=C1C#N HAAHMAILBWIUSO-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- FDGUZCMQOHCDOY-UHFFFAOYSA-M [I-].CCCCCCCCCC[Zn+] Chemical compound [I-].CCCCCCCCCC[Zn+] FDGUZCMQOHCDOY-UHFFFAOYSA-M 0.000 description 12
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 12
- 229960004132 diethyl ether Drugs 0.000 description 12
- 239000011777 magnesium Substances 0.000 description 12
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 11
- 239000002274 desiccant Substances 0.000 description 11
- 238000001914 filtration Methods 0.000 description 11
- 239000011133 lead Substances 0.000 description 11
- CPRRHERYRRXBRZ-SRVKXCTJSA-N methyl n-[(2s)-1-[[(2s)-1-hydroxy-3-[(3s)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate Chemical compound COC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CO)C[C@@H]1CCNC1=O CPRRHERYRRXBRZ-SRVKXCTJSA-N 0.000 description 11
- 238000006862 quantum yield reaction Methods 0.000 description 11
- 229960000583 acetic acid Drugs 0.000 description 10
- 229910052744 lithium Inorganic materials 0.000 description 10
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 10
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 9
- VEQPNABPJHWNSG-UHFFFAOYSA-N Nickel(2+) Chemical compound [Ni+2] VEQPNABPJHWNSG-UHFFFAOYSA-N 0.000 description 9
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 238000001953 recrystallisation Methods 0.000 description 9
- 239000007858 starting material Substances 0.000 description 9
- PUFIXALSROVACG-UHFFFAOYSA-N 4,5-dibromo-3,6-dihydroxybenzene-1,2-dicarbonitrile Chemical compound OC1=C(Br)C(Br)=C(O)C(C#N)=C1C#N PUFIXALSROVACG-UHFFFAOYSA-N 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical class [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 8
- 239000012362 glacial acetic acid Substances 0.000 description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- 238000004809 thin layer chromatography Methods 0.000 description 8
- SKTSZLTUDJZCEX-UHFFFAOYSA-N 3,6-diphenylbenzene-1,2-dicarbonitrile Chemical compound N#CC=1C(C#N)=C(C=2C=CC=CC=2)C=CC=1C1=CC=CC=C1 SKTSZLTUDJZCEX-UHFFFAOYSA-N 0.000 description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 229910000024 caesium carbonate Inorganic materials 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 125000004093 cyano group Chemical group *C#N 0.000 description 7
- 125000000524 functional group Chemical group 0.000 description 7
- 239000002502 liposome Substances 0.000 description 7
- ZBRJXVVKPBZPAN-UHFFFAOYSA-L nickel(2+);triphenylphosphane;dichloride Chemical compound [Cl-].[Cl-].[Ni+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 ZBRJXVVKPBZPAN-UHFFFAOYSA-L 0.000 description 7
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 239000011592 zinc chloride Substances 0.000 description 7
- 235000005074 zinc chloride Nutrition 0.000 description 7
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 7
- PXLFZVNSJRPRPT-UHFFFAOYSA-N 3,6-bis(6-imidazol-1-ylhexyl)benzene-1,2-dicarbonitrile Chemical compound C1=CC(CCCCCCN2C=NC=C2)=C(C#N)C(C#N)=C1CCCCCCN1C=CN=C1 PXLFZVNSJRPRPT-UHFFFAOYSA-N 0.000 description 6
- NTJBPRBBLQKOTL-UHFFFAOYSA-N 3,6-dibutoxy-4-[4-(hydroxymethyl)phenyl]benzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(CO)=CC=2)=C1OCCCC NTJBPRBBLQKOTL-UHFFFAOYSA-N 0.000 description 6
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 6
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 6
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 150000001336 alkenes Chemical class 0.000 description 6
- 150000001350 alkyl halides Chemical class 0.000 description 6
- 239000012298 atmosphere Substances 0.000 description 6
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical class P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000010408 film Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- 239000003504 photosensitizing agent Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 6
- KYPOHTVBFVELTG-OWOJBTEDSA-N (e)-but-2-enedinitrile Chemical compound N#C\C=C\C#N KYPOHTVBFVELTG-OWOJBTEDSA-N 0.000 description 5
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 5
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 5
- SKIDNYUZJPMKFC-UHFFFAOYSA-N 1-iododecane Chemical compound CCCCCCCCCCI SKIDNYUZJPMKFC-UHFFFAOYSA-N 0.000 description 5
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 5
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 5
- ZWDXFPRCFLWNBO-UHFFFAOYSA-N 3,6-bis(4-methoxyphenyl)benzene-1,2-dicarbonitrile Chemical compound C1=CC(OC)=CC=C1C(C(=C1C#N)C#N)=CC=C1C1=CC=C(OC)C=C1 ZWDXFPRCFLWNBO-UHFFFAOYSA-N 0.000 description 5
- PUUJFDXHWZXBLV-UHFFFAOYSA-N 3,6-bis(6-chlorohexyl)benzene-1,2-dicarbonitrile Chemical compound ClCCCCCCC1=CC=C(CCCCCCCl)C(C#N)=C1C#N PUUJFDXHWZXBLV-UHFFFAOYSA-N 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 5
- 229910002666 PdCl2 Inorganic materials 0.000 description 5
- WFCUIQRFFXLLMA-UHFFFAOYSA-M [Cl-].CCCCCCC#C[Zn+] Chemical compound [Cl-].CCCCCCC#C[Zn+] WFCUIQRFFXLLMA-UHFFFAOYSA-M 0.000 description 5
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 5
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- 238000010626 work up procedure Methods 0.000 description 5
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 5
- VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 4
- SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 4
- DRLUTAGZMJJXGQ-UHFFFAOYSA-N 3,6-bis(3-methoxyphenyl)benzene-1,2-dicarbonitrile Chemical compound COC1=CC=CC(C=2C(=C(C#N)C(C=3C=C(OC)C=CC=3)=CC=2)C#N)=C1 DRLUTAGZMJJXGQ-UHFFFAOYSA-N 0.000 description 4
- HLWHEMMJDQNAPJ-UHFFFAOYSA-N 3,6-bis(decylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCCCCSC1=CC=C(SCCCCCCCCCC)C(C#N)=C1C#N HLWHEMMJDQNAPJ-UHFFFAOYSA-N 0.000 description 4
- PKUNOLIHEQYMCI-UHFFFAOYSA-N 3,6-bis(dodecylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCCCCCCSC1=CC=C(SCCCCCCCCCCCC)C(C#N)=C1C#N PKUNOLIHEQYMCI-UHFFFAOYSA-N 0.000 description 4
- UUMCRBQWJBUMCW-UHFFFAOYSA-N 3,6-bis(hexylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCSC1=CC=C(SCCCCCC)C(C#N)=C1C#N UUMCRBQWJBUMCW-UHFFFAOYSA-N 0.000 description 4
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 4
- DFKKJQABUJCNLE-UHFFFAOYSA-N 4-(hydrazinylmethyl)phenol Chemical compound NNCC1=CC=C(O)C=C1 DFKKJQABUJCNLE-UHFFFAOYSA-N 0.000 description 4
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000005804 alkylation reaction Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 4
- 150000001502 aryl halides Chemical class 0.000 description 4
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 239000003426 co-catalyst Substances 0.000 description 4
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 4
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 4
- HOXINJBQVZWYGZ-UHFFFAOYSA-N fenbutatin oxide Chemical compound C=1C=CC=CC=1C(C)(C)C[Sn](O[Sn](CC(C)(C)C=1C=CC=CC=1)(CC(C)(C)C=1C=CC=CC=1)CC(C)(C)C=1C=CC=CC=1)(CC(C)(C)C=1C=CC=CC=1)CC(C)(C)C1=CC=CC=C1 HOXINJBQVZWYGZ-UHFFFAOYSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000004973 liquid crystal related substance Substances 0.000 description 4
- 150000002736 metal compounds Chemical class 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 208000017983 photosensitivity disease Diseases 0.000 description 4
- 231100000434 photosensitization Toxicity 0.000 description 4
- JUJWROOIHBZHMG-RALIUCGRSA-N pyridine-d5 Chemical compound [2H]C1=NC([2H])=C([2H])C([2H])=C1[2H] JUJWROOIHBZHMG-RALIUCGRSA-N 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical compound C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 4
- YZYKBQUWMPUVEN-UHFFFAOYSA-N zafuleptine Chemical compound OC(=O)CCCCCC(C(C)C)NCC1=CC=C(F)C=C1 YZYKBQUWMPUVEN-UHFFFAOYSA-N 0.000 description 4
- NLLGFYPSWCMUIV-UHFFFAOYSA-N (3-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1 NLLGFYPSWCMUIV-UHFFFAOYSA-N 0.000 description 3
- FIRODXFCQOQZSE-UHFFFAOYSA-N (8-bromoquinolin-4-yl)methanol Chemical compound C1=CC=C2C(CO)=CC=NC2=C1Br FIRODXFCQOQZSE-UHFFFAOYSA-N 0.000 description 3
- BMYRXJQPTUJNCF-UHFFFAOYSA-N 3,6-bis(4-chlorobutyl)benzene-1,2-dicarbonitrile Chemical compound ClCCCCC1=CC=C(CCCCCl)C(C#N)=C1C#N BMYRXJQPTUJNCF-UHFFFAOYSA-N 0.000 description 3
- GXFSEGQRWQOYFV-UHFFFAOYSA-N 3,6-dibutoxy-4-(4-methoxyphenyl)benzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(OC)=CC=2)=C1OCCCC GXFSEGQRWQOYFV-UHFFFAOYSA-N 0.000 description 3
- IIBMGBRQXLEZPD-UHFFFAOYSA-N 3,6-dibutoxy-4-[4-(dimethylamino)phenyl]benzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(=CC=2)N(C)C)=C1OCCCC IIBMGBRQXLEZPD-UHFFFAOYSA-N 0.000 description 3
- ZLPCKQYOZCZIKL-UHFFFAOYSA-N 3,6-dibutoxy-4-phenylbenzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC=CC=2)=C1OCCCC ZLPCKQYOZCZIKL-UHFFFAOYSA-N 0.000 description 3
- AMKGKYQBASDDJB-UHFFFAOYSA-N 9$l^{2}-borabicyclo[3.3.1]nonane Chemical compound C1CCC2CCCC1[B]2 AMKGKYQBASDDJB-UHFFFAOYSA-N 0.000 description 3
- FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo[3.3.1]nonane Substances C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 description 3
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- 101000738322 Homo sapiens Prothymosin alpha Proteins 0.000 description 3
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 3
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 3
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 description 3
- 238000006619 Stille reaction Methods 0.000 description 3
- 238000006069 Suzuki reaction reaction Methods 0.000 description 3
- 102100033632 Tropomyosin alpha-1 chain Human genes 0.000 description 3
- VQFXQNFXFGACHE-UHFFFAOYSA-N [4-(2,5-dibutoxy-3,4-dicyanophenyl)phenyl]methyl methanesulfonate Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(COS(C)(=O)=O)=CC=2)=C1OCCCC VQFXQNFXFGACHE-UHFFFAOYSA-N 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 229910000085 borane Inorganic materials 0.000 description 3
- 229910052796 boron Inorganic materials 0.000 description 3
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 3
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- YWFGJRGXFPIQDZ-UHFFFAOYSA-N ethyl 4-(2,5-dibutoxy-3,4-dicyanophenyl)butanoate Chemical compound CCCCOC1=CC(CCCC(=O)OCC)=C(OCCCC)C(C#N)=C1C#N YWFGJRGXFPIQDZ-UHFFFAOYSA-N 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 238000002143 fast-atom bombardment mass spectrum Methods 0.000 description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- LTRVAZKHJRYLRJ-UHFFFAOYSA-N lithium;butan-1-olate Chemical compound [Li+].CCCC[O-] LTRVAZKHJRYLRJ-UHFFFAOYSA-N 0.000 description 3
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 238000005649 metathesis reaction Methods 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 229940078487 nickel acetate tetrahydrate Drugs 0.000 description 3
- OINIXPNQKAZCRL-UHFFFAOYSA-L nickel(2+);diacetate;tetrahydrate Chemical compound O.O.O.O.[Ni+2].CC([O-])=O.CC([O-])=O OINIXPNQKAZCRL-UHFFFAOYSA-L 0.000 description 3
- ZOUWOGOTHLRRLS-UHFFFAOYSA-N palladium;phosphane Chemical compound P.[Pd] ZOUWOGOTHLRRLS-UHFFFAOYSA-N 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- WWBGWPHHLRSTFI-UHFFFAOYSA-N phenalen-1-one Chemical compound C1=CC(C(=O)C=C2)=C3C2=CC=CC3=C1 WWBGWPHHLRSTFI-UHFFFAOYSA-N 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 230000000886 photobiology Effects 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 229940001584 sodium metabisulfite Drugs 0.000 description 3
- 235000010262 sodium metabisulphite Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 3
- 239000011135 tin Substances 0.000 description 3
- YEMJHNYABQHWHL-UHFFFAOYSA-N tributyl(ethynyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C#C YEMJHNYABQHWHL-UHFFFAOYSA-N 0.000 description 3
- UYMSTSQPXWFMFR-UHFFFAOYSA-N tridecylborane Chemical compound BCCCCCCCCCCCCC UYMSTSQPXWFMFR-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XPARCVGSTPKNNR-UHFFFAOYSA-M zinc;ethyl butanoate;bromide Chemical compound [Zn+2].[Br-].CCOC(=O)CC[CH2-] XPARCVGSTPKNNR-UHFFFAOYSA-M 0.000 description 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 2
- XRILZZJFFXPAEL-UHFFFAOYSA-N (2,3-dicyano-4-decylphenyl) trifluoromethanesulfonate Chemical compound CCCCCCCCCCC1=CC=C(OS(=O)(=O)C(F)(F)F)C(C#N)=C1C#N XRILZZJFFXPAEL-UHFFFAOYSA-N 0.000 description 2
- APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- PMBXCGGQNSVESQ-UHFFFAOYSA-N 1-Hexanethiol Chemical compound CCCCCCS PMBXCGGQNSVESQ-UHFFFAOYSA-N 0.000 description 2
- VBWZXZKZQWHCOM-UHFFFAOYSA-N 2,5-dibutoxy-4-(2,3-dicyanophenyl)benzoic acid Chemical compound C1=C(C(O)=O)C(OCCCC)=CC(C=2C(=C(C#N)C=CC=2)C#N)=C1OCCCC VBWZXZKZQWHCOM-UHFFFAOYSA-N 0.000 description 2
- XGLVDUUYFKXKPL-UHFFFAOYSA-N 2-(2-methoxyethoxy)-n,n-bis[2-(2-methoxyethoxy)ethyl]ethanamine Chemical compound COCCOCCN(CCOCCOC)CCOCCOC XGLVDUUYFKXKPL-UHFFFAOYSA-N 0.000 description 2
- ZNJRONVKWRHYBF-UHFFFAOYSA-N 2-[2-[2-(1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-yl)ethenyl]-6-methylpyran-4-ylidene]propanedinitrile Chemical compound O1C(C)=CC(=C(C#N)C#N)C=C1C=CC1=CC(CCCN2CCC3)=C2C3=C1 ZNJRONVKWRHYBF-UHFFFAOYSA-N 0.000 description 2
- HELXNKJXGBWXDN-UHFFFAOYSA-N 3,6-bis[4-[tert-butyl(dimethyl)silyl]oxybutyl]benzene-1,2-dicarbonitrile Chemical compound CC(C)(C)[Si](C)(C)OCCCCC1=CC=C(CCCCO[Si](C)(C)C(C)(C)C)C(C#N)=C1C#N HELXNKJXGBWXDN-UHFFFAOYSA-N 0.000 description 2
- VIWINWVCKDNVIZ-UHFFFAOYSA-N 3,6-di(piperidin-1-yl)benzene-1,2-dicarbonitrile Chemical compound N#CC=1C(C#N)=C(N2CCCCC2)C=CC=1N1CCCCC1 VIWINWVCKDNVIZ-UHFFFAOYSA-N 0.000 description 2
- GRXBDNNMZVJQNZ-UHFFFAOYSA-N 3,6-dibutoxy-4-(4-chlorobutyl)benzene-1,2-dicarbonitrile Chemical compound CCCCOC1=CC(CCCCCl)=C(OCCCC)C(C#N)=C1C#N GRXBDNNMZVJQNZ-UHFFFAOYSA-N 0.000 description 2
- DNIMPKVOFJESNJ-UHFFFAOYSA-N 3,6-dibutoxy-4-pyridin-4-ylbenzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CN=CC=2)=C1OCCCC DNIMPKVOFJESNJ-UHFFFAOYSA-N 0.000 description 2
- CMWOPHRVYNICBF-UHFFFAOYSA-N 3,6-dibutoxy-4-thiophen-2-ylbenzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2SC=CC=2)=C1OCCCC CMWOPHRVYNICBF-UHFFFAOYSA-N 0.000 description 2
- RJFAMAFEWDBSLX-UHFFFAOYSA-N 3,6-dibutoxybenzene-1,2-dicarbonitrile Chemical group CCCCOC1=CC=C(OCCCC)C(C#N)=C1C#N RJFAMAFEWDBSLX-UHFFFAOYSA-N 0.000 description 2
- NLTIETZTDSJANS-UHFFFAOYSA-N 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=NC=C1 NLTIETZTDSJANS-UHFFFAOYSA-N 0.000 description 2
- RTLUPHDWSUGAOS-UHFFFAOYSA-N 4-iodopyridine Chemical compound IC1=CC=NC=C1 RTLUPHDWSUGAOS-UHFFFAOYSA-N 0.000 description 2
- FAOJEIKFLZQLBH-UHFFFAOYSA-N 7-iodo-2,2-dimethylheptan-3-one Chemical compound CC(C)(C)C(=O)CCCCI FAOJEIKFLZQLBH-UHFFFAOYSA-N 0.000 description 2
- 241001120493 Arene Species 0.000 description 2
- KLYCPFXDDDMZNQ-UHFFFAOYSA-N Benzyne Chemical compound C1=CC#CC=C1 KLYCPFXDDDMZNQ-UHFFFAOYSA-N 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 238000007341 Heck reaction Methods 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 238000006411 Negishi coupling reaction Methods 0.000 description 2
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 108091000054 Prion Proteins 0.000 description 2
- 102000029797 Prion Human genes 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- JKCYUAPVJLZDCT-UHFFFAOYSA-N [2,3-dicyano-4-(1,1,2,2,3,3,4,4,4-nonafluorobutylsulfonyloxy)phenyl] 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)S(=O)(=O)OC1=CC=C(OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(C#N)=C1C#N JKCYUAPVJLZDCT-UHFFFAOYSA-N 0.000 description 2
- MZLTWBHTTDHCAV-UHFFFAOYSA-N [2,3-dicyano-4-(trifluoromethylsulfonyloxy)naphthalen-1-yl] trifluoromethanesulfonate Chemical compound C1=CC=C2C(OS(=O)(=O)C(F)(F)F)=C(C#N)C(C#N)=C(OS(=O)(=O)C(F)(F)F)C2=C1 MZLTWBHTTDHCAV-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- CSCPPACGZOOCGX-WFGJKAKNSA-N acetone d6 Chemical compound [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 150000001356 alkyl thiols Chemical class 0.000 description 2
- 239000012036 alkyl zinc reagent Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 150000001503 aryl iodides Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 150000005347 biaryls Chemical class 0.000 description 2
- AFYNADDZULBEJA-UHFFFAOYSA-N bicinchoninic acid Chemical compound C1=CC=CC2=NC(C=3C=C(C4=CC=CC=C4N=3)C(=O)O)=CC(C(O)=O)=C21 AFYNADDZULBEJA-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- VTXVGVNLYGSIAR-UHFFFAOYSA-N decane-1-thiol Chemical compound CCCCCCCCCCS VTXVGVNLYGSIAR-UHFFFAOYSA-N 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- GSFZBNQNAIJHGO-UHFFFAOYSA-N ethyl 4-[2,3-dicyano-4-(4-ethoxy-4-oxobutyl)phenyl]butanoate Chemical compound CCOC(=O)CCCC1=CC=C(CCCC(=O)OCC)C(C#N)=C1C#N GSFZBNQNAIJHGO-UHFFFAOYSA-N 0.000 description 2
- 238000001506 fluorescence spectroscopy Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004795 grignard reagents Chemical class 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- PSCMQHVBLHHWTO-UHFFFAOYSA-K indium(iii) chloride Chemical compound Cl[In](Cl)Cl PSCMQHVBLHHWTO-UHFFFAOYSA-K 0.000 description 2
- 238000007917 intracranial administration Methods 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- OSGLSBFNYYVAOR-UHFFFAOYSA-N lithium;oct-1-yne Chemical compound [Li+].CCCCCCC#[C-] OSGLSBFNYYVAOR-UHFFFAOYSA-N 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- GRWIABMEEKERFV-UHFFFAOYSA-N methanol;oxolane Chemical compound OC.C1CCOC1 GRWIABMEEKERFV-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 2
- BMGNSKKZFQMGDH-FDGPNNRMSA-L nickel(2+);(z)-4-oxopent-2-en-2-olate Chemical compound [Ni+2].C\C([O-])=C\C(C)=O.C\C([O-])=C\C(C)=O BMGNSKKZFQMGDH-FDGPNNRMSA-L 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 2
- 238000007339 nucleophilic aromatic substitution reaction Methods 0.000 description 2
- 125000001979 organolithium group Chemical group 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 150000002940 palladium Chemical class 0.000 description 2
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- LUYQYZLEHLTPBH-UHFFFAOYSA-N perfluorobutanesulfonyl fluoride Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)S(F)(=O)=O LUYQYZLEHLTPBH-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 2
- 238000001907 polarising light microscopy Methods 0.000 description 2
- 238000012746 preparative thin layer chromatography Methods 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000005316 response function Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- ARYHTUPFQTUBBG-UHFFFAOYSA-N thiophen-2-ylboronic acid Chemical compound OB(O)C1=CC=CS1 ARYHTUPFQTUBBG-UHFFFAOYSA-N 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- 238000005809 transesterification reaction Methods 0.000 description 2
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- BPLUKJNHPBNVQL-UHFFFAOYSA-N triphenylarsine Chemical compound C1=CC=CC=C1[As](C=1C=CC=CC=1)C1=CC=CC=C1 BPLUKJNHPBNVQL-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 2
- YSDBSMVMRBYHRH-UHFFFAOYSA-N (2,3-dicyanophenyl) 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)S(=O)(=O)OC1=CC=CC(C#N)=C1C#N YSDBSMVMRBYHRH-UHFFFAOYSA-N 0.000 description 1
- MKPDAJWEBQRQCO-UHFFFAOYSA-N (4-aminophenyl)boronic acid Chemical compound NC1=CC=C(B(O)O)C=C1 MKPDAJWEBQRQCO-UHFFFAOYSA-N 0.000 description 1
- AKYHKWQPZHDOBW-UHFFFAOYSA-N (5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol Chemical compound OS(O)(=O)=O.C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 AKYHKWQPZHDOBW-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- YYOGYQNNOGKIFI-UHFFFAOYSA-N 1,4-bis(3-methoxyphenyl)cyclohexa-3,5-diene-1,2-dicarbonitrile Chemical compound COC1=CC=CC(C=2C=CC(C(C#N)C=2)(C#N)C=2C=C(OC)C=CC=2)=C1 YYOGYQNNOGKIFI-UHFFFAOYSA-N 0.000 description 1
- JJBQXTABLSZHGC-UHFFFAOYSA-N 1,4-dihydroxynaphthalene-2,3-dicarbonitrile Chemical compound C1=CC=C2C(O)=C(C#N)C(C#N)=C(O)C2=C1 JJBQXTABLSZHGC-UHFFFAOYSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- REFDOIWRJDGBHY-UHFFFAOYSA-N 2-bromobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Br)=C1 REFDOIWRJDGBHY-UHFFFAOYSA-N 0.000 description 1
- PYEQXZOIQJWYAH-UHFFFAOYSA-N 2-bromocyclohexa-2,5-diene-1,4-dione Chemical compound BrC1=CC(=O)C=CC1=O PYEQXZOIQJWYAH-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- CFIYISMWOOTOLG-UHFFFAOYSA-N 3,6-bis(6,6-dimethyl-5-oxoheptyl)benzene-1,2-dicarbonitrile Chemical compound CC(C)(C)C(=O)CCCCC1=CC=C(CCCCC(=O)C(C)(C)C)C(C#N)=C1C#N CFIYISMWOOTOLG-UHFFFAOYSA-N 0.000 description 1
- GOPNQBNDBLKOGZ-UHFFFAOYSA-N 3,6-bis(heptylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCSC1=CC=C(SCCCCCCC)C(C#N)=C1C#N GOPNQBNDBLKOGZ-UHFFFAOYSA-N 0.000 description 1
- VMNBVZXPKRYDHE-UHFFFAOYSA-N 3,6-bis(nonylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCCCSC1=CC=C(SCCCCCCCCC)C(C#N)=C1C#N VMNBVZXPKRYDHE-UHFFFAOYSA-N 0.000 description 1
- YPFCPDDBDOIGHD-UHFFFAOYSA-N 3,6-bis(octylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCCSC1=CC=C(SCCCCCCCC)C(C#N)=C1C#N YPFCPDDBDOIGHD-UHFFFAOYSA-N 0.000 description 1
- ZEPIONWMIXGQDP-UHFFFAOYSA-N 3,6-bis(undecylsulfanyl)benzene-1,2-dicarbonitrile Chemical compound CCCCCCCCCCCSC1=CC=C(SCCCCCCCCCCC)C(C#N)=C1C#N ZEPIONWMIXGQDP-UHFFFAOYSA-N 0.000 description 1
- GLTAPYYPPPWROQ-UHFFFAOYSA-N 3,6-dibutoxy-4,5-diphenylbenzene-1,2-dicarbonitrile Chemical compound C=1C=CC=CC=1C=1C(OCCCC)=C(C#N)C(C#N)=C(OCCCC)C=1C1=CC=CC=C1 GLTAPYYPPPWROQ-UHFFFAOYSA-N 0.000 description 1
- APUOFYQGISEQAA-UHFFFAOYSA-N 3,6-dibutoxy-4-(4-oxohexyl)benzene-1,2-dicarbonitrile Chemical compound CCCCOC1=CC(CCCC(=O)CC)=C(OCCCC)C(C#N)=C1C#N APUOFYQGISEQAA-UHFFFAOYSA-N 0.000 description 1
- MWFHEIJPUOXWRI-UHFFFAOYSA-N 3-[2-tri(propan-2-yl)silylethynyl]benzene-1,2-dicarbonitrile Chemical compound C(C)(C)[Si](C(C)C)(C(C)C)C#CC1=C(C(C#N)=CC=C1)C#N MWFHEIJPUOXWRI-UHFFFAOYSA-N 0.000 description 1
- OYPIAMMBWHEBHP-UHFFFAOYSA-N 4-(2,5-dibutoxy-3,4-dicyanophenyl)benzoic acid Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(=CC=2)C(O)=O)=C1OCCCC OYPIAMMBWHEBHP-UHFFFAOYSA-N 0.000 description 1
- KGYBWMZQDGCJSE-UHFFFAOYSA-N 4-(4-aminophenyl)-3,6-dibutoxybenzene-1,2-dicarbonitrile Chemical compound N#CC1=C(C#N)C(OCCCC)=CC(C=2C=CC(N)=CC=2)=C1OCCCC KGYBWMZQDGCJSE-UHFFFAOYSA-N 0.000 description 1
- XEUXQSZILBIIEJ-UHFFFAOYSA-N 4-[2,3-dicyano-4-[4-(2,2-dimethylpropanoyloxy)butyl]phenyl]butyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCCCC1=CC=C(CCCCOC(=O)C(C)(C)C)C(C#N)=C1C#N XEUXQSZILBIIEJ-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102100024321 Alkaline phosphatase, placental type Human genes 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- 229910015845 BBr3 Inorganic materials 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- GODBKCACSIIRTK-UHFFFAOYSA-N BrC=1C(=C(C(C#N)=C(C1)OCCCC)C#N)OCCCC.S1C(=CC=C1)C=1C(=C(C(C#N)=C(C1)OCCCC)C#N)OCCCC Chemical compound BrC=1C(=C(C(C#N)=C(C1)OCCCC)C#N)OCCCC.S1C(=CC=C1)C=1C(=C(C(C#N)=C(C1)OCCCC)C#N)OCCCC GODBKCACSIIRTK-UHFFFAOYSA-N 0.000 description 1
- TUBFQIZCXOIUFS-MYYCVZOESA-N C(#C)C1(O)[C@](O)([C@@](O)([C@](O)([C@H](O1)C(O)C(C)=O)C(C)=O)C(C)=O)C(C)=O Chemical compound C(#C)C1(O)[C@](O)([C@@](O)([C@](O)([C@H](O1)C(O)C(C)=O)C(C)=O)C(C)=O)C(C)=O TUBFQIZCXOIUFS-MYYCVZOESA-N 0.000 description 1
- 125000006416 CBr Chemical group BrC* 0.000 description 1
- PBEHMIMZBVHCBF-UHFFFAOYSA-N CCCCCCCCCCCCCCCCCC[Zn] Chemical compound CCCCCCCCCCCCCCCCCC[Zn] PBEHMIMZBVHCBF-UHFFFAOYSA-N 0.000 description 1
- 125000006519 CCH3 Chemical group 0.000 description 1
- 101100219382 Caenorhabditis elegans cah-2 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000819038 Chichester Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000001576 FEMA 2977 Substances 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- GOTYPHJYOIRENG-QRPNPIFTSA-N OBO.OC(=O)[C@@H](N)CC1=CC=CC=C1 Chemical class OBO.OC(=O)[C@@H](N)CC1=CC=CC=C1 GOTYPHJYOIRENG-QRPNPIFTSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000010642 Porphyrias Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 239000004990 Smectic liquid crystal Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 238000006161 Suzuki-Miyaura coupling reaction Methods 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- ILNGGQHFWCWSCL-UHFFFAOYSA-N [3,4-dicyano-2-(trifluoromethylsulfonyloxy)phenyl] trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC=C(C#N)C(C#N)=C1OS(=O)(=O)C(F)(F)F ILNGGQHFWCWSCL-UHFFFAOYSA-N 0.000 description 1
- PZRPBPMLSSNFOM-UHFFFAOYSA-N [4-(hydroxymethyl)phenyl]boronic acid Chemical compound OCC1=CC=C(B(O)O)C=C1 PZRPBPMLSSNFOM-UHFFFAOYSA-N 0.000 description 1
- CKCYDFVZAPRMBQ-UHFFFAOYSA-M [Cl-].CCCCCCCCCC[Mg+] Chemical compound [Cl-].CCCCCCCCCC[Mg+] CKCYDFVZAPRMBQ-UHFFFAOYSA-M 0.000 description 1
- IYRNUFOFIFCJLO-UHFFFAOYSA-M [Cl-].CCCCCCCCCC[Zn+] Chemical compound [Cl-].CCCCCCCCCC[Zn+] IYRNUFOFIFCJLO-UHFFFAOYSA-M 0.000 description 1
- RTXGBJFGTBKZSZ-UHFFFAOYSA-M [F-].[Cs+].N1=CC=C(C=C1)C=1C(=C(C(C#N)=C(C1)OCCCC)C#N)OCCCC Chemical compound [F-].[Cs+].N1=CC=C(C=C1)C=1C(=C(C(C#N)=C(C1)OCCCC)C#N)OCCCC RTXGBJFGTBKZSZ-UHFFFAOYSA-M 0.000 description 1
- QEPKILSISOJIPK-UHFFFAOYSA-M [I-].CC(C)(C)C(=O)CCCC[Zn+] Chemical compound [I-].CC(C)(C)C(=O)CCCC[Zn+] QEPKILSISOJIPK-UHFFFAOYSA-M 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- MQRWBMAEBQOWAF-UHFFFAOYSA-N acetic acid;nickel Chemical compound [Ni].CC(O)=O.CC(O)=O MQRWBMAEBQOWAF-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000002820 allylidene group Chemical group [H]C(=[*])C([H])=C([H])[H] 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 238000010640 amide synthesis reaction Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 150000001499 aryl bromides Chemical class 0.000 description 1
- 150000001500 aryl chlorides Chemical class 0.000 description 1
- 238000005311 autocorrelation function Methods 0.000 description 1
- 238000005815 base catalysis Methods 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000005620 boronic acid group Chemical class 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 229960004407 chorionic gonadotrophin Drugs 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000007324 demetalation reaction Methods 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 239000002027 dichloromethane extract Substances 0.000 description 1
- ZHXTWWCDMUWMDI-UHFFFAOYSA-N dihydroxyboron Chemical compound O[B]O ZHXTWWCDMUWMDI-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 1
- FMVJYQGSRWVMQV-UHFFFAOYSA-N ethyl propiolate Chemical compound CCOC(=O)C#C FMVJYQGSRWVMQV-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 238000006197 hydroboration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000012052 hydrophilic carrier Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000005113 hydroxyalkoxy group Chemical group 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- APHGZSBLRQFRCA-UHFFFAOYSA-M indium(1+);chloride Chemical compound [In]Cl APHGZSBLRQFRCA-UHFFFAOYSA-M 0.000 description 1
- PEGSDTJEVCWNKC-UHFFFAOYSA-M indium(3+);chloride Chemical compound [In+2]Cl PEGSDTJEVCWNKC-UHFFFAOYSA-M 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000003041 laboratory chemical Substances 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 150000002680 magnesium Chemical class 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001254 matrix assisted laser desorption--ionisation time-of-flight mass spectrum Methods 0.000 description 1
- 238000003328 mesylation reaction Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 239000002032 methanolic fraction Substances 0.000 description 1
- WJYBMWHJTZBYSO-UHFFFAOYSA-N methyl 3-bromobutanoate Chemical compound COC(=O)CC(C)Br WJYBMWHJTZBYSO-UHFFFAOYSA-N 0.000 description 1
- MWZPENIJLUWBSY-VIFPVBQESA-N methyl L-tyrosinate Chemical compound COC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MWZPENIJLUWBSY-VIFPVBQESA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- HQFYIDOMCULPIW-UHFFFAOYSA-N n-methylprop-2-yn-1-amine Chemical compound CNCC#C HQFYIDOMCULPIW-UHFFFAOYSA-N 0.000 description 1
- AZKDTTQQTKDXLH-UHFFFAOYSA-N naphthalene-2-carbonitrile Chemical compound C1=CC=CC2=CC(C#N)=CC=C21 AZKDTTQQTKDXLH-UHFFFAOYSA-N 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 150000002815 nickel Chemical class 0.000 description 1
- 229940078494 nickel acetate Drugs 0.000 description 1
- KFBKRCXOTTUAFS-UHFFFAOYSA-N nickel;triphenylphosphane Chemical compound [Ni].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 KFBKRCXOTTUAFS-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M nitrite group Chemical group N(=O)[O-] IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000005151 nonafluorobutanesulfonyl group Chemical group FC(C(C(S(=O)(=O)*)(F)F)(F)F)(C(F)(F)F)F 0.000 description 1
- UMIPWJGWASORKV-UHFFFAOYSA-N oct-1-yne Chemical compound CCCCCCC#C UMIPWJGWASORKV-UHFFFAOYSA-N 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- OTYPIDNRISCWQY-UHFFFAOYSA-L palladium(2+);tris(2-methylphenyl)phosphane;dichloride Chemical compound Cl[Pd]Cl.CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C.CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C OTYPIDNRISCWQY-UHFFFAOYSA-L 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002987 phenanthrenes Chemical class 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- DETAHNVSLBCZAA-ARJGXJLFSA-N photo product Chemical compound C[C@@H]([C@]12O)[C@@H](OC(C)=O)[C@@]3(OC(C)=O)C(C)(C)C3[C@@H]2C2[C@]3(COC(C)=O)C[C@]4(O)[C@H]1C2[C@@]3(C)C4=O DETAHNVSLBCZAA-ARJGXJLFSA-N 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 230000002165 photosensitisation Effects 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 208000007578 phototoxic dermatitis Diseases 0.000 description 1
- 231100000018 phototoxicity Toxicity 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 108010031345 placental alkaline phosphatase Proteins 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000006238 prop-1-en-1-yl group Chemical group [H]\C(*)=C(/[H])C([H])([H])[H] 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 229960003110 quinine sulfate Drugs 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 231100000489 sensitizer Toxicity 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 125000005017 substituted alkenyl group Chemical group 0.000 description 1
- 125000005415 substituted alkoxy group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000004426 substituted alkynyl group Chemical group 0.000 description 1
- 238000004781 supercooling Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- INGJYKISFRSCQV-UHFFFAOYSA-N tert-butyl-(4-iodobutoxy)-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)OCCCCI INGJYKISFRSCQV-UHFFFAOYSA-N 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- UMHFSEWKWORSLP-UHFFFAOYSA-N thiophene 1,1-dioxide Chemical class O=S1(=O)C=CC=C1 UMHFSEWKWORSLP-UHFFFAOYSA-N 0.000 description 1
- 238000001161 time-correlated single photon counting Methods 0.000 description 1
- YXFVVABEGXRONW-JGUCLWPXSA-N toluene-d8 Chemical compound [2H]C1=C([2H])C([2H])=C(C([2H])([2H])[2H])C([2H])=C1[2H] YXFVVABEGXRONW-JGUCLWPXSA-N 0.000 description 1
- 238000006478 transmetalation reaction Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- LGQXXHMEBUOXRP-UHFFFAOYSA-N tributyl borate Chemical compound CCCCOB(OCCCC)OCCCC LGQXXHMEBUOXRP-UHFFFAOYSA-N 0.000 description 1
- 150000008648 triflates Chemical class 0.000 description 1
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 1
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000010887 waste solvent Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B47/00—Porphines; Azaporphines
- C09B47/04—Phthalocyanines abbreviation: Pc
- C09B47/045—Special non-pigmentary uses, e.g. catalyst, photosensitisers of phthalocyanine dyes or pigments
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B47/00—Porphines; Azaporphines
- C09B47/04—Phthalocyanines abbreviation: Pc
- C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
- C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B47/00—Porphines; Azaporphines
- C09B47/04—Phthalocyanines abbreviation: Pc
- C09B47/06—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
- C09B47/067—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
- C09B47/0673—Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile having alkyl radicals linked directly to the Pc skeleton; having carbocyclic groups linked directly to the skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nanotechnology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Theoretical Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Mathematical Physics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9929064.5A GB9929064D0 (en) | 1999-12-08 | 1999-12-08 | Substituted phthalocyanines and their precursors |
| GB9929064.5 | 1999-12-08 | ||
| GB0012348A GB0012348D0 (en) | 1999-12-08 | 2000-05-22 | Substituted phthalocyanines and their precursors |
| GB0012348.9 | 2000-05-22 | ||
| GBGB0025817.8A GB0025817D0 (en) | 1999-12-08 | 2000-10-20 | Substituted phthalocyanines and their precursors |
| GB0025817.8 | 2000-10-20 | ||
| PCT/GB2000/004708 WO2001042368A1 (en) | 1999-12-08 | 2000-12-08 | Substituted phthalocyanines and their precursors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2394891A1 true CA2394891A1 (en) | 2001-06-14 |
Family
ID=27255732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002394891A Abandoned CA2394891A1 (en) | 1999-12-08 | 2000-12-08 | Substituted phthalocyanines and their precursors |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1238016A1 (et) |
| JP (1) | JP2003516421A (et) |
| AU (1) | AU2192201A (et) |
| CA (1) | CA2394891A1 (et) |
| CZ (1) | CZ20021974A3 (et) |
| EE (1) | EE200200298A (et) |
| HU (1) | HUP0301099A3 (et) |
| NO (1) | NO20022663L (et) |
| PL (1) | PL355851A1 (et) |
| WO (1) | WO2001042368A1 (et) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004529171A (ja) * | 2001-03-21 | 2004-09-24 | エル.モルテニ エ シー.デイ フラテッリ アリッチ ソシエタ’ディ エセルチヅィオ ソシエタ ペル アチオニ | 金属置換非中心対称性フタロシアニン類似体、それらの調製、及び光線力学療法ならびに生体内診断における使用 |
| EP1346971B1 (en) | 2002-03-18 | 2010-01-20 | Sumitomo Chemical Company, Limited | Production method for biarylalanine |
| CN100415715C (zh) * | 2003-02-11 | 2008-09-03 | 杜锡光 | 紫菜嗪环中具有六个异吲哚结构亚单元的超酞菁类化合物、合成方法及用途 |
| MXPA05012165A (es) * | 2003-05-14 | 2006-05-19 | Univ Sherbrooke | Porfirazinas amfifilicas trisulfonadas para aplicaciones fotodinamicas en medicina. |
| JP4809657B2 (ja) * | 2005-09-29 | 2011-11-09 | 富士フイルム株式会社 | ナフタロシアニン色素およびその製造方法 |
| JP4942351B2 (ja) * | 2006-01-31 | 2012-05-30 | 独立行政法人科学技術振興機構 | 光線力学治療抗癌剤 |
| JP5296355B2 (ja) * | 2007-09-11 | 2013-09-25 | 株式会社日本触媒 | アリール基含有フタロシアニン化合物、その製造方法、及び、配合物 |
| US8168359B2 (en) * | 2008-03-10 | 2012-05-01 | Xerox Corporation | Nanosized particles of phthalocyanine pigments |
| CZ303612B6 (cs) * | 2010-08-19 | 2013-01-09 | Výzkumný ústav organických syntéz a.s. | Sloucenina pro fotodynamickou inaktivaci soucasne grampozitivních bakterií, gramnegativních bakterií a patogenních kvasinek, na bázi derivátu ftalocyaninu, a pouzití této slouceniny |
| JP2012167189A (ja) * | 2011-02-14 | 2012-09-06 | Aisin Seiki Co Ltd | フタロシアニン誘導体、フタロシアニン誘導体の製造方法および色素増感型太陽電池 |
| JP2013193956A (ja) * | 2012-03-15 | 2013-09-30 | Saitama Univ | tetrakis−トリアルキルまたはフェニルシリルエチニル置換フタロシアニンおよびその製造方法 |
| JP6278386B2 (ja) * | 2013-11-06 | 2018-02-14 | 国立研究開発法人産業技術総合研究所 | フタロシアニン化合物及び有機半導体材料 |
| CN103864645B (zh) * | 2013-12-30 | 2016-08-17 | 常州大学 | 一种二取代全氟烷基邻苯二甲腈化合物及其制备方法 |
| CN104016995A (zh) * | 2014-06-26 | 2014-09-03 | 常州大学 | 八取代全氟烷基钴酞菁化合物及其制备方法 |
| JP6608187B2 (ja) * | 2015-06-22 | 2019-11-20 | 山本化成株式会社 | 増感色素、半導体電極、光電変換素子および色素増感太陽電池 |
| EP3287451B1 (de) | 2016-08-24 | 2019-12-11 | Cynora Gmbh | Organische moleküle, insbesondere zur verwendung in organischen optoelektronischen vorrichtungen |
| CN108017650A (zh) * | 2017-03-08 | 2018-05-11 | 先尼科化工(上海)有限公司 | 一种用于滤光片的酞菁化合物及其制备方法和应用方法 |
| JP6922361B2 (ja) * | 2017-04-07 | 2021-08-18 | Jsr株式会社 | 固体撮像素子用組成物、赤外線遮蔽膜及び固体撮像素子 |
| CN110494501B (zh) * | 2017-04-07 | 2022-04-19 | 山本化成株式会社 | 酞菁系化合物、及其用途 |
| WO2018186490A1 (ja) * | 2017-04-07 | 2018-10-11 | 山本化成株式会社 | ナフタロシアニン化合物、その製造方法および用途 |
| WO2020071470A1 (ja) * | 2018-10-05 | 2020-04-09 | 山本化成株式会社 | フタロシアニン系化合物、及びその用途 |
| CN112279856B (zh) * | 2019-07-24 | 2021-09-17 | 南方科技大学 | 一种非外围取代的可溶性金属酞菁及其合成方法和应用、一种钙钛矿太阳能电池 |
| CN112014383B (zh) * | 2020-06-30 | 2024-03-29 | 杜旭忠 | 一种用于均相化学发光的光敏剂及其制备方法和应用 |
| US20230279034A1 (en) * | 2020-07-31 | 2023-09-07 | Sumitomo Chemical Company, Limited | Compound |
| CN112812299B (zh) * | 2020-12-31 | 2022-03-29 | 四川大学 | 邻苯二甲腈与氨基酸环肽共聚树脂及其制备方法 |
| JPWO2022196089A1 (et) * | 2021-03-15 | 2022-09-22 | ||
| EP4574911A1 (en) | 2023-12-22 | 2025-06-25 | Holland Colours N. V. | Bio-sourced phthalocyanine complex, preparation and use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0155780B1 (en) * | 1984-03-21 | 1990-03-28 | Imperial Chemical Industries Plc | Infra-red absorber |
| GB8431446D0 (en) * | 1984-12-13 | 1985-01-23 | Secr Defence | Alkoxyphthalocyanines |
| GB8619238D0 (en) * | 1986-08-06 | 1986-09-17 | Ici Plc | Organic photoconductor |
| EP0346354B1 (en) * | 1987-02-13 | 1992-08-19 | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and | Substituted phthalocyanines |
| JPH0730300B2 (ja) * | 1988-04-01 | 1995-04-05 | 三井東圧化学株式会社 | アルキルフタロシアニン近赤外線吸収剤及びそれを用いた表示・記録材料 |
| CA2005520A1 (en) * | 1988-12-15 | 1990-06-15 | Hisato Itoh | Near infrared absorbent and display/recording materials prepared by using same |
| JPH07103093B2 (ja) * | 1989-01-12 | 1995-11-08 | 三井東圧化学株式会社 | フタロニトリル系化合物およびその製造方法 |
| EP0519423B1 (en) * | 1991-06-19 | 1999-03-03 | Mitsui Chemicals, Inc. | Phthalocyanine compounds and usage thereof |
| ATE174942T1 (de) * | 1991-11-08 | 1999-01-15 | Eastman Chem Co | Thermoplastische polymerzusammensetzung welche eine oder mehrere monomere, im nahen infarot fluoreszierende verbindungen, darin vermischt enthält |
| GB9317881D0 (en) * | 1993-08-27 | 1993-10-13 | Secr Defence | Photosensitizers |
| US5456998A (en) * | 1994-04-26 | 1995-10-10 | Xerox Corporation | Photoconductive imaging members containing alkoxy-bridged metallophthalocyanine dimers |
| JPH0892190A (ja) * | 1994-09-26 | 1996-04-09 | Kanto Chem Co Inc | シアノビフェニル誘導体並びにそれらを含む液晶組成物 |
| GB9613476D0 (en) * | 1996-06-27 | 1996-08-28 | British Polythene Ltd | Improvements in or relating to films and/or coatings |
| IT1294325B1 (it) * | 1997-08-14 | 1999-03-24 | Molteni L E C Dei Fratelli Ali | Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici |
| WO2000021965A1 (en) * | 1998-10-13 | 2000-04-20 | Brown University Research Foundation | Substituted perhalogenated phthalocyanines |
-
2000
- 2000-12-08 EE EEP200200298A patent/EE200200298A/et unknown
- 2000-12-08 CA CA002394891A patent/CA2394891A1/en not_active Abandoned
- 2000-12-08 HU HU0301099A patent/HUP0301099A3/hu unknown
- 2000-12-08 CZ CZ20021974A patent/CZ20021974A3/cs unknown
- 2000-12-08 AU AU21922/01A patent/AU2192201A/en not_active Abandoned
- 2000-12-08 JP JP2001543656A patent/JP2003516421A/ja active Pending
- 2000-12-08 WO PCT/GB2000/004708 patent/WO2001042368A1/en not_active Ceased
- 2000-12-08 EP EP00985506A patent/EP1238016A1/en not_active Withdrawn
- 2000-12-08 PL PL00355851A patent/PL355851A1/xx not_active Application Discontinuation
-
2002
- 2002-06-05 NO NO20022663A patent/NO20022663L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001042368A1 (en) | 2001-06-14 |
| NO20022663L (no) | 2002-08-08 |
| JP2003516421A (ja) | 2003-05-13 |
| EE200200298A (et) | 2003-08-15 |
| CZ20021974A3 (cs) | 2002-11-13 |
| HUP0301099A3 (en) | 2003-11-28 |
| EP1238016A1 (en) | 2002-09-11 |
| NO20022663D0 (no) | 2002-06-05 |
| HUP0301099A2 (hu) | 2003-08-28 |
| AU2192201A (en) | 2001-06-18 |
| PL355851A1 (en) | 2004-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2394891A1 (en) | Substituted phthalocyanines and their precursors | |
| Güzel et al. | Synthesis, characterization and photodynamic activity of a new amphiphilic zinc phthalocyanine | |
| Roeder et al. | Photophysical properties and photodynamic activity in vivo of some tetrapyrroles | |
| Ge et al. | Azadipyrromethenes: from traditional dye chemistry to leading edge applications | |
| Garci et al. | Tunable arene ruthenium metallaprisms to transport, shield, and release porphin in cancer cells | |
| Woehrle et al. | Synthesis and photochemical properties of phthalocyanine zinc (II) complexes containing o-carborane units | |
| CN108727256A (zh) | 一种基于三苯胺多吡啶盐的光敏剂及其制备方法与应用 | |
| de Oliveira et al. | Synthesis of phthalocyanines− ALA conjugates: water-soluble compounds with low aggregation | |
| Tabrizi et al. | New cyclometalated Ir (III) complexes with NCN pincer and meso-phenylcyanamide BODIPY ligands as efficient photodynamic therapy agents | |
| WO2002096913A1 (en) | Substituted di(hydroxy/alkoxy)silicon phthalocyanines and their uses | |
| Weimin et al. | Synthesis and in vitro PDT activity of miscellaneous porphyrins with amino acid and uracil | |
| Rojo et al. | Methylation and demethylation in cobaltabis (dicarbollide) derivatives | |
| Brunner et al. | Benzoporphyrins and acetylene-substituted porphyrins as improved photosensitizers in the photodynamic tumor therapy with porphyrin platinum conjugates | |
| EP1492799B1 (en) | Compounds useful as photodynamic therapeutic agents | |
| Zaki et al. | Synthesis and crystal structure elucidation of new copper (II)-based chemotherapeutic agent coupled with 1, 2-DACH and orthovanillin: Validated by in vitro DNA/HSA binding profile and pBR322 cleavage pathway | |
| Chen et al. | Fluorinated coumarin silicon (IV)/zinc (II) phthalocyanines: Synthesis, photophysical properties and photoinduced intramolecular energy transfer | |
| CN113512066B (zh) | 索拉非尼-钌配合物及其制备方法和应用 | |
| CN116178305A (zh) | 一类基于光诱导的卡宾前体化合物及其应用 | |
| CN100374442C (zh) | 硼化金属酞菁类及其制备方法,包含它们的医药组合物及其用途 | |
| Song et al. | Model studies of the (6–4) photoproduct photoreactivation: Efficient photosensitized splitting of thymine oxetane units by covalently linked tryptophan in high polarity solvents | |
| CN1329400C (zh) | 二碳代-闭合式-十二硼烷衍生物 | |
| CA2399217A1 (en) | Porphyrins and related compounds | |
| RU2193563C2 (ru) | Окта-4,5-карбоксифталоцианины как фотосенсибилизаторы для фотодинамической терапии | |
| Pineda | Synthesis and Application of Caged-Fluorescent Probes | |
| CN118666727B (zh) | 一种硫鎓类聚集诱导发光光敏剂及制备与应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |